Market Closed -
Nyse
21:00:02 26/04/2024 BST
|
5-day change
|
1st Jan Change
|
237.4
USD
|
+2.79%
|
|
+3.59%
|
+16.72%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,737
|
5,066
|
6,294
|
7,277
|
6,006
|
7,194
|
-
|
-
|
Enterprise Value (EV)
1 |
1,737
|
4,857
|
6,105
|
6,826
|
5,546
|
6,644
|
6,538
|
6,383
|
P/E ratio
|
-53
x
|
-85.9
x
|
-149
x
|
-157
x
|
-283
x
|
-603
x
|
308
x
|
125
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
21.2
x
|
43.9
x
|
27
x
|
17.8
x
|
9.61
x
|
9.2
x
|
7.57
x
|
6.3
x
|
EV / Revenue
|
21.2
x
|
42.1
x
|
26.2
x
|
16.7
x
|
8.88
x
|
8.49
x
|
6.88
x
|
5.59
x
|
EV / EBITDA
|
-61.6
x
|
-114
x
|
-158
x
|
1,095
x
|
123
x
|
101
x
|
56.3
x
|
40.2
x
|
EV / FCF
|
-48.8
x
|
-87.5
x
|
-246
x
|
2,760
x
|
5,416
x
|
110
x
|
75.8
x
|
51.4
x
|
FCF Yield
|
-2.05%
|
-1.14%
|
-0.41%
|
0.04%
|
0.02%
|
0.91%
|
1.32%
|
1.94%
|
Price to Book
|
12.8
x
|
21.3
x
|
27.4
x
|
-
|
10.5
x
|
10.9
x
|
9.17
x
|
7.38
x
|
Nbr of stocks (in thousands)
|
23,402
|
26,935
|
27,358
|
28,892
|
29,524
|
30,297
|
-
|
-
|
Reference price
2 |
74.21
|
188.1
|
230.1
|
251.9
|
203.4
|
237.4
|
237.4
|
237.4
|
Announcement Date
|
25/02/20
|
23/02/21
|
08/02/22
|
07/02/23
|
06/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
82.05
|
115.4
|
233.4
|
407.9
|
624.8
|
782.1
|
950.3
|
1,142
|
EBITDA
1 |
-28.2
|
-42.55
|
-38.63
|
6.236
|
45.04
|
66.07
|
116.1
|
158.9
|
EBIT
1 |
-34.9
|
-56.21
|
-39.85
|
-47.59
|
-40.27
|
-29.19
|
5.613
|
63.01
|
Operating Margin
|
-42.53%
|
-48.72%
|
-17.07%
|
-11.67%
|
-6.45%
|
-3.73%
|
0.59%
|
5.52%
|
Earnings before Tax (EBT)
1 |
-33.2
|
-57.09
|
-41.97
|
-44.27
|
-19.91
|
-6.869
|
27.63
|
54.49
|
Net income
1 |
-33.24
|
-57.2
|
-42.04
|
-44.88
|
-21.15
|
-9.047
|
24.19
|
67.44
|
Net margin
|
-40.52%
|
-49.58%
|
-18.01%
|
-11%
|
-3.39%
|
-1.16%
|
2.55%
|
5.9%
|
EPS
2 |
-1.400
|
-2.190
|
-1.540
|
-1.600
|
-0.7200
|
-0.3936
|
0.7713
|
1.905
|
Free Cash Flow
1 |
-35.58
|
-55.5
|
-24.79
|
2.473
|
1.024
|
60.6
|
86.3
|
124.1
|
FCF margin
|
-43.37%
|
-48.1%
|
-10.62%
|
0.61%
|
0.16%
|
7.75%
|
9.08%
|
10.86%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
39.66%
|
2.27%
|
91.72%
|
74.35%
|
78.07%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
356.8%
|
183.98%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
25/02/20
|
23/02/21
|
08/02/22
|
07/02/23
|
06/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
61.68
|
78.4
|
69.38
|
91.39
|
109.2
|
137.9
|
127.9
|
151.1
|
153.3
|
192.5
|
161.1
|
188
|
196.8
|
235.4
|
202.9
|
EBITDA
1 |
-2.65
|
-1.477
|
-15.7
|
-0.931
|
-2.092
|
15.24
|
-0.68
|
5.627
|
1.895
|
32.96
|
-1.415
|
12.44
|
18.66
|
40.47
|
1.844
|
EBIT
1 |
-9.796
|
-1.821
|
-16.06
|
-14.01
|
-17.19
|
-0.335
|
-19.5
|
-16.6
|
-13.47
|
9.297
|
-25.76
|
-12.26
|
-7.169
|
15.88
|
-13.9
|
Operating Margin
|
-15.88%
|
-2.32%
|
-23.14%
|
-15.33%
|
-15.75%
|
-0.24%
|
-15.25%
|
-10.99%
|
-8.79%
|
4.83%
|
-15.99%
|
-6.52%
|
-3.64%
|
6.75%
|
-6.85%
|
Earnings before Tax (EBT)
1 |
-10.34
|
-2.371
|
-16.59
|
-14.35
|
-16.6
|
3.275
|
-15.21
|
-11.74
|
-8.2
|
15.24
|
-19.97
|
-6.914
|
-0.9652
|
20.92
|
-7.974
|
Net income
1 |
-10.35
|
-2.391
|
-16.69
|
-14.49
|
-16.85
|
3.15
|
-15.42
|
-11.95
|
-8.54
|
14.76
|
-19.71
|
-6.772
|
-1.148
|
18.51
|
-7.54
|
Net margin
|
-16.77%
|
-3.05%
|
-24.06%
|
-15.86%
|
-15.43%
|
2.28%
|
-12.06%
|
-7.91%
|
-5.57%
|
7.67%
|
-12.24%
|
-3.6%
|
-0.58%
|
7.86%
|
-3.72%
|
EPS
2 |
-0.3800
|
-0.0900
|
-0.6100
|
-0.5300
|
-0.6000
|
0.1000
|
-0.5300
|
-0.4100
|
-0.2900
|
0.4900
|
-0.6747
|
-0.2254
|
-0.0610
|
0.5772
|
-0.2463
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
02/11/21
|
08/02/22
|
03/05/22
|
02/08/22
|
01/11/22
|
07/02/23
|
02/05/23
|
01/08/23
|
07/11/23
|
06/02/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
210
|
189
|
451
|
460
|
550
|
656
|
811
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-35.6
|
-55.5
|
-24.8
|
2.47
|
1.02
|
60.6
|
86.3
|
124
|
ROE (net income / shareholders' equity)
|
-21.9%
|
-31%
|
-18.3%
|
-12.4%
|
-3.96%
|
-2.79%
|
2.08%
|
6.34%
|
ROA (Net income/ Total Assets)
|
-
|
-24.7%
|
-14.6%
|
-10.4%
|
-3.41%
|
-2.35%
|
0.2%
|
1.9%
|
Assets
1 |
-
|
231.2
|
288.1
|
430
|
620.9
|
385
|
12,094
|
3,550
|
Book Value Per Share
2 |
5.800
|
8.810
|
8.400
|
-
|
19.40
|
21.70
|
25.90
|
32.20
|
Cash Flow per Share
2 |
-1.380
|
-2.030
|
-
|
0.4100
|
0.8400
|
0.8400
|
2.320
|
-
|
Capex
1 |
2.74
|
2.46
|
4.67
|
9.1
|
23.6
|
19.7
|
26.6
|
31.3
|
Capex / Sales
|
3.34%
|
2.13%
|
2%
|
2.23%
|
3.78%
|
2.52%
|
2.8%
|
2.74%
|
Announcement Date
|
25/02/20
|
23/02/21
|
08/02/22
|
07/02/23
|
06/02/24
|
-
|
-
|
-
|
Last Close Price
237.4
USD Average target price
253.8
USD Spread / Average Target +6.88% Consensus |
1st Jan change
|
Capi.
|
---|
| +16.72% | 7.19B | | +12.07% | 128B | | -9.04% | 10.65B | | +0.91% | 8.82B | | +25.15% | 4.99B | | +7.17% | 3.4B | | -1.36% | 3.03B | | -8.73% | 2.14B | | -10.15% | 2B | | -22.81% | 1.79B |
Medical Devices & Implants
|